BMJ editor urges Roche to fulfil promise to release Tamiflu trial data

Journal launches open data campaign to compel greater accountability in healthcare

2012-10-30

(Press-News.org) In an open letter to company director, Professor Sir John Bell, she says: "Billions of pounds of public money have been spent on [Tamiflu] and yet the evidence on its effectiveness and safety remains hidden from appropriate and necessary independent scrutiny."

The letter is published on the BMJ's website (bmj.com/tamiflu ) alongside correspondence by the Cochrane team with Roche, the US Centres for Disease Control (CDC) and the World Health Organisation (WHO), as part of an open data campaign aimed at persuading Roche to give doctors and patients access to the full data on Tamiflu.

Dr Godlee's letter follows recent reports that the European Medicines Agency (EMA) has initiated infringement proceedings against Roche to investigate deficiencies in safety reporting, including the processing of around 80,000 reports on suspected adverse drug reactions.

Dr Godlee is also one of 28 signaturies to a letter published in The Times today (thetimes.co.uk/letters) calling on drug companies to "come clean" and make clinical trial data for all drugs in current use available to healthcare professionals.

Pressure from politicians is also mounting. Last week, Sarah Wollaston, a GP and Conservative MP, raised the issue of missing data in Parliament, while Health Minister Norman Lamb has agreed to meet experts to discuss the issue of access to clinical trial data.

In December 2009, Roche made a public promise to release full clinical trial reports of its antiviral drug oseltamivir (Tamiflu) in response to a major investigation by the BMJ and researchers Peter Doshi and Tom Jefferson from the Cochrane Collaboration.

The investigation found no clear evidence that Tamiflu prevents complications like pneumonia in healthy people. It also raised serious concerns about access to drug data, the use of ghost writers in drug trials, and the drug approval process.

Since the investigation, some further data have been released to the Cochrane reviewers, but the full data set has still not been provided.

The Cochrane reviewers now know that there are at least 123 trials of Tamiflu and that the majority (60%) of patient data from Roche Phase 3 completed treatment trials remain unpublished. Their main concerns relate to "the likely overstating of effectiveness and the apparent under-reporting of potentially serious adverse effects."

Meanwhile, Tamiflu has been a great commercial success for Roche and has been added to the World Health Organisation's list of essential medicines.

In her letter, Dr Godlee appeals to Professor Bell "to bring your influence to bear on your colleagues on Roche's board." She adds: "In refusing to release these data of enormous public interest, you put Roche outside the circle of responsible pharmaceutical companies. Releasing the data would do a great deal to restore confidence in your company and its board of directors."

In a response not for publication, Professor Bell said he has referred the matter to Roche and is awaiting a response.

"The open correspondence on bmj.com aims to hold specific individuals and organisations to account," writes Dr Godlee in an accompanying editorial. "Their actions are preventing independent scrutiny of the results of clinical trials and putting patients' lives at risk. We also hope it will contribute to a sea change in the public mood."

A poll on bmj.com last week asked: "Who is mainly at fault for denying access to negative clinical trial results?" Of the 569 votes, 69% said pharma, 13.5% said regulators, and 9% said legislators.

The BMJ plans to launch other campaigns linked to its investigations in the future.

### END

ELSE PRESS RELEASES FROM THIS DATE:

More than good vibes: Researchers propose the science behind mindfulness

2012-10-30

BOSTON, MA—Achieving mindfulness through meditation has helped people maintain a healthy mind by quelling negative emotions and thoughts, such as desire, anger and anxiety, and encouraging more positive dispositions such as compassion, empathy and forgiveness. Those who have reaped the benefits of mindfulness know that it works. But how exactly does it work? Researchers at Brigham and Women's Hospital (BWH) have proposed a new model that shifts how we think about mindfulness. Rather than describing mindfulness as a single dimension of cognition, the researchers demonstrate ...

Some cancer survivors reported poor health-related quality of life years after diagnosis

2012-10-30

PHILADELPHIA — Survivors of many common cancers enjoy a mental and physical health-related quality of life equal to that of adults who have not had cancer, but survivors of other cancers are in poorer health, according to results published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. "We did not have a good sense of how cancer survivors across the United States were faring after their cancer diagnosis and immediate treatment," said Kathryn E. Weaver, Ph.D., M.P.H., assistant professor at Wake Forest Baptist ...

Mastering weight-maintenance skills before embarking on diet helps women avoid backsliding

2012-10-30

STANFORD, Calif. — Would you take part in a weight-loss program in which you were explicitly asked not to lose any weight for the first eight weeks? Although the approach sounds counterintuitive, a study from researchers at the Stanford University School of Medicine found that women who spent eight weeks mastering weight-maintenance skills before embarking on a weight-loss program shed the same number of pounds as women who started a weight-loss program immediately. More importantly, the study showed that the "maintenance-first" women had regained only 3 pounds on average ...

Many cancer survivors face health-related quality of life issues

2012-10-30

WINSTON-SALEM, N.C. – Oct. 30, 2012 – Beating cancer is just the first step. More than one third of the 12.6 million cancer survivors in the United States have physical or mental problems that put their overall health in jeopardy, according to researchers at Wake Forest Baptist Medical Center. Their study, published in the October issue of the journal Cancer Epidemiology, Biomarkers & Prevention, found that 25 percent of cancer survivors reported poor physical health and 10 percent reported poor mental health as compared to 10 percent and 6 percent, respectively, of adults ...

Distinct developmental patterns identified in children with autism during their first 3 years

2012-10-30

In the largest prospective study to date of children with early and later manifestation of autism spectrum disorders (ASD) compared to children without ASD, researchers found two distinct patterns of language, social and motor development in the children with ASD. Published in the journal Child Development, the study found that early in development, children who display early signs of ASD show greater initial delay across multiple aspects of development compared to children whose ASD symptoms emerge later. However at 36 months of age, the early differences between these ...

Milton Collier NEW Book! Good Economy and Bad Economy - The Right Career

2012-10-30

No matter what the economy is doing at any given time, goods must be transported to consumers. These factors may be a good reason to take a look at the Transportation Industry. The book Good Economy and Bad Economy, The Right Career, demonstrates that transportation professionals can leverage their experience to enter many fields in the industry. Milton Collier, the author is the President of TranZcenter, LLC (http://www.TranZcenter.com) retired military veteran with over 25 years or experience in the Transportation Industry. The book is current sold on Amazon at (https://www.createspace.com/3792235) ...

Annals of Internal Medicine tip sheet for Oct. 30, 2012

2012-10-30

Health care expenditures are projected to reach almost 20 percent of the United States' GDP by 2020. Many economists consider this spending rate unsustainable. Up to 30 percent, or $765 billion, of health care costs were identified as potentially avoidable -- with many of these costs attributed to inappropriate or unnecessary services. Evidence-based performance measures for low-value tests and treatments can be one of the ways to help physicians to provide high value care to their patients, according to the American College of Physicians (ACP) in a new policy paper published ...

Migraine in children may affect school performance

2012-10-30

MINNEAPOLIS – Children with migraine are more likely to have below average school performance than kids who do not have headaches, according to new research published in the October 30, 2012, print issue of Neurology®, the medical journal of the American Academy of Neurology. The study of 5,671 Brazilian children ages 5 to 12 found that those with migraine were 30 percent more likely to have below average school performance than those with no headaches. "Studies have looked at the burden of migraine for adolescents, but less work has been done to determine the effect ...

Canada's health costs for seniors rising slowly: Points way to Medicare solvency

2012-10-30

A study published in today's [Monday, Oct. 29] Archives of Internal Medicine finds that per capita Medicare spending on the elderly has grown nearly three times faster in the United States than in Canada since 1980. (Canada's program, which covers all Canadians, not just the elderly, is also called Medicare.) Cost grew more slowly in Canada despite a 1984 law banning co-payments and deductibles. In the first study of its kind, Dr. David U. Himmelstein and Dr. Steffie Woolhandler, professors at the City University of New York's School of Public Health, analyzed decades ...

Ethnic disparities in breast cancer survival remain despite socioeconomic similarities

2012-10-30

SAN DIEGO — Disparities in survival after breast cancer persisted across racial/ethnic groups even after researchers adjusted for multiple demographics, such as patients' education and the socioeconomic status of the neighborhood in which they lived, according to data presented at the Fifth AACR Conference on The Science of Cancer Health Disparities, held here Oct. 27-30, 2012. "We learned that the effects of neighborhood socioeconomic status differed by racial/ethnic group. When simultaneously accounting for race/ethnicity and socioeconomic status, we found persistent ...

Exploring the scientific connotation of the medicinal properties of toad venom (Chansu) — 'dispersing fire stagnation and opening orifices to awaken the spirit' — from the microscopic world of 5-HTR d

BMJ editor urges Roche to fulfil promise to release Tamiflu trial data

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: